Cargando…
Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209975/ https://www.ncbi.nlm.nih.gov/pubmed/37250929 http://dx.doi.org/10.14744/hf.2022.2022.0033 |
_version_ | 1785046978828173312 |
---|---|
author | Caliskan, Ali Riza Muhip Harputluoglu, Muhsin Murat Samdanci, Emine Cirik, Salih Yilmaz, Sezai |
author_facet | Caliskan, Ali Riza Muhip Harputluoglu, Muhsin Murat Samdanci, Emine Cirik, Salih Yilmaz, Sezai |
author_sort | Caliskan, Ali Riza |
collection | PubMed |
description | Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 – year – old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis. |
format | Online Article Text |
id | pubmed-10209975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Kare Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-102099752023-05-26 Fingolimod induced fulminant liver failure requiring liver transplantation: A case report Caliskan, Ali Riza Muhip Harputluoglu, Muhsin Murat Samdanci, Emine Cirik, Salih Yilmaz, Sezai Hepatol Forum Case Report Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 – year – old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis. Kare Publishing 2023-05-18 /pmc/articles/PMC10209975/ /pubmed/37250929 http://dx.doi.org/10.14744/hf.2022.2022.0033 Text en © Copyright 2023 by Hepatology Forum https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Case Report Caliskan, Ali Riza Muhip Harputluoglu, Muhsin Murat Samdanci, Emine Cirik, Salih Yilmaz, Sezai Fingolimod induced fulminant liver failure requiring liver transplantation: A case report |
title | Fingolimod induced fulminant liver failure requiring liver transplantation: A case report |
title_full | Fingolimod induced fulminant liver failure requiring liver transplantation: A case report |
title_fullStr | Fingolimod induced fulminant liver failure requiring liver transplantation: A case report |
title_full_unstemmed | Fingolimod induced fulminant liver failure requiring liver transplantation: A case report |
title_short | Fingolimod induced fulminant liver failure requiring liver transplantation: A case report |
title_sort | fingolimod induced fulminant liver failure requiring liver transplantation: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209975/ https://www.ncbi.nlm.nih.gov/pubmed/37250929 http://dx.doi.org/10.14744/hf.2022.2022.0033 |
work_keys_str_mv | AT caliskanaliriza fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport AT muhipharputluoglumuhsinmurat fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport AT samdanciemine fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport AT ciriksalih fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport AT yilmazsezai fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport |